Brookfield Corp’s Novartis NVS Stock Holding History

Brookfield Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-38,968	Closed	-$3.54M	–	747
2022 Q4	$3.54M	Sell	38,968 -156,776	-80%	-$13.2M	0.01%	321
2022 Q3	$14.9M	Buy	195,744 +90,571	+86%	+$7.51M	0.05%	114
2022 Q2	$8.89M	Buy	+105,173	New	+$9.23M	0.04%	167

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Brookfield Corp's NVS Position: Q1 2023 in Review

Brookfield Corp sold out of Novartis (NVS) in Q1 2023, closing a stake of 38,968 shares — an estimated $3.54M sold.

Brookfield Corp first reported a position in NVS in Q2 2022 and held it in 3 quarters. The position peaked at $14.9M in Q3 2022. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.

Brookfield Corp reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 38,968 Novartis shares in Q1 2023, an estimated $3.54M.
Brookfield Corp first reported a position in Novartis in Q2 2022 and held it in 3 quarters.
Brookfield Corp's Novartis position peaked at $14.9M in Q3 2022.
1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.